Global NK Cells market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Get access now!

Global NK Cells Market Trends and Opportunities 2025-31

The global NK Cells market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Natural killer lymphocytes: NK cells for short, are differentiated from lymphocytes in the bone marrow, accounting for 2% to 5% of the total number of lymphocytes in the blood. NK cells are widely distributed in the human body, in peripheral blood and spleen. , NK cell activity is highest in lymph nodes. NK cells are present in the lamina propria of hollow organ walls and in the interstitium of some solid organs. NK cell activity is lower in bone marrow. NK cells are large lymphocytes with an average diameter of 12~15?m, with more cytoplasm, and many azurophilic granules of different sizes in the cytoplasm, so it is also called large granular lymphocyte (LGL). The nucleus is oval, and under the electron microscope, the cells are The azurophilic granules in the cytoplasm are lysosomes. The chromatin in the nucleus is rich, and heterochromatin is mostly at the edge. There are short microvilli on the cell surface. NK cells do not need antigen activation, let alone the assistance of antibodies. They can Directly killing target cells, such as virus-infected cells and tumor cells, the anti-infection and anti-tumor killing effects of NK cells are broad-spectrum. United States market for NK Cells is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for NK Cells is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for NK Cells is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key NK Cells players cover Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the NK Cells Industry Forecast looks at past sales and reviews total world NK Cells sales in 2024, providing a comprehensive analysis by region and market sector of projected NK Cells sales for 2025 through 2031. With NK Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NK Cells industry. This Insight Report provides a comprehensive analysis of the global NK Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on NK Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global NK Cells market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NK Cells and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NK Cells. This report presents a comprehensive overview, market shares, and growth opportunities of NK Cells market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Mogamulizumab &nbsp;&nbsp;&nbsp; Lorvotuzumab Mertansine &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Cancer &nbsp;&nbsp;&nbsp; Cardiovascular Diseases &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Chipscreen Biosciences &nbsp;&nbsp;&nbsp; Affimed NV &nbsp;&nbsp;&nbsp; Altor BioScience &nbsp;&nbsp;&nbsp; Innate Pharma &nbsp;&nbsp;&nbsp; Takeda &nbsp;&nbsp;&nbsp; Sorrento Therapeutics &nbsp;&nbsp;&nbsp; NantKwest &nbsp;&nbsp;&nbsp; Bristol-Myers Squibb &nbsp;&nbsp;&nbsp; NKT &nbsp;&nbsp;&nbsp; Henry Ford Health Services &nbsp;&nbsp;&nbsp; Fortress Biotech Key Questions Addressed in this Report What is the 10-year outlook for the global NK Cells market? What factors are driving NK Cells market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do NK Cells market opportunities vary by end market size? How does NK Cells break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global NK Cells Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for NK Cells by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for NK Cells by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 NK Cells Segment by Type &nbsp;2.2.1 Mogamulizumab &nbsp;2.2.2 Lorvotuzumab Mertansine &nbsp;2.2.3 Others &nbsp;2.3 NK Cells Sales by Type &nbsp;2.3.1 Global NK Cells Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global NK Cells Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global NK Cells Sale Price by Type (2020-2025) &nbsp;2.4 NK Cells Segment by Application &nbsp;2.4.1 Cancer &nbsp;2.4.2 Cardiovascular Diseases &nbsp;2.4.3 Others &nbsp;2.5 NK Cells Sales by Application &nbsp;2.5.1 Global NK Cells Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global NK Cells Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global NK Cells Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global NK Cells Breakdown Data by Company &nbsp;3.1.1 Global NK Cells Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global NK Cells Sales Market Share by Company (2020-2025) &nbsp;3.2 Global NK Cells Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global NK Cells Revenue by Company (2020-2025) &nbsp;3.2.2 Global NK Cells Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global NK Cells Sale Price by Company &nbsp;3.4 Key Manufacturers NK Cells Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers NK Cells Product Location Distribution &nbsp;3.4.2 Players NK Cells Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for NK Cells by Geographic Region &nbsp;4.1 World Historic NK Cells Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global NK Cells Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global NK Cells Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic NK Cells Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global NK Cells Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global NK Cells Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas NK Cells Sales Growth &nbsp;4.4 APAC NK Cells Sales Growth &nbsp;4.5 Europe NK Cells Sales Growth &nbsp;4.6 Middle East & Africa NK Cells Sales Growth 5 Americas &nbsp;5.1 Americas NK Cells Sales by Country &nbsp;5.1.1 Americas NK Cells Sales by Country (2020-2025) &nbsp;5.1.2 Americas NK Cells Revenue by Country (2020-2025) &nbsp;5.2 Americas NK Cells Sales by Type (2020-2025) &nbsp;5.3 Americas NK Cells Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC NK Cells Sales by Region &nbsp;6.1.1 APAC NK Cells Sales by Region (2020-2025) &nbsp;6.1.2 APAC NK Cells Revenue by Region (2020-2025) &nbsp;6.2 APAC NK Cells Sales by Type (2020-2025) &nbsp;6.3 APAC NK Cells Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe NK Cells by Country &nbsp;7.1.1 Europe NK Cells Sales by Country (2020-2025) &nbsp;7.1.2 Europe NK Cells Revenue by Country (2020-2025) &nbsp;7.2 Europe NK Cells Sales by Type (2020-2025) &nbsp;7.3 Europe NK Cells Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa NK Cells by Country &nbsp;8.1.1 Middle East & Africa NK Cells Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa NK Cells Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa NK Cells Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa NK Cells Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of NK Cells &nbsp;10.3 Manufacturing Process Analysis of NK Cells &nbsp;10.4 Industry Chain Structure of NK Cells 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 NK Cells Distributors &nbsp;11.3 NK Cells Customer 12 World Forecast Review for NK Cells by Geographic Region &nbsp;12.1 Global NK Cells Market Size Forecast by Region &nbsp;12.1.1 Global NK Cells Forecast by Region (2026-2031) &nbsp;12.1.2 Global NK Cells Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global NK Cells Forecast by Type (2026-2031) &nbsp;12.7 Global NK Cells Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Chipscreen Biosciences &nbsp;13.1.1 Chipscreen Biosciences Company Information &nbsp;13.1.2 Chipscreen Biosciences NK Cells Product Portfolios and Specifications &nbsp;13.1.3 Chipscreen Biosciences NK Cells Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Chipscreen Biosciences Main Business Overview &nbsp;13.1.5 Chipscreen Biosciences Latest Developments &nbsp;13.2 Affimed NV &nbsp;13.2.1 Affimed NV Company Information &nbsp;13.2.2 Affimed NV NK Cells Product Portfolios and Specifications &nbsp;13.2.3 Affimed NV NK Cells Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Affimed NV Main Business Overview &nbsp;13.2.5 Affimed NV Latest Developments &nbsp;13.3 Altor BioScience &nbsp;13.3.1 Altor BioScience Company Information &nbsp;13.3.2 Altor BioScience NK Cells Product Portfolios and Specifications &nbsp;13.3.3 Altor BioScience NK Cells Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Altor BioScience Main Business Overview &nbsp;13.3.5 Altor BioScience Latest Developments &nbsp;13.4 Innate Pharma &nbsp;13.4.1 Innate Pharma Company Information &nbsp;13.4.2 Innate Pharma NK Cells Product Portfolios and Specifications &nbsp;13.4.3 Innate Pharma NK Cells Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Innate Pharma Main Business Overview &nbsp;13.4.5 Innate Pharma Latest Developments &nbsp;13.5 Takeda &nbsp;13.5.1 Takeda Company Information &nbsp;13.5.2 Takeda NK Cells Product Portfolios and Specifications &nbsp;13.5.3 Takeda NK Cells Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Takeda Main Business Overview &nbsp;13.5.5 Takeda Latest Developments &nbsp;13.6 Sorrento Therapeutics &nbsp;13.6.1 Sorrento Therapeutics Company Information &nbsp;13.6.2 Sorrento Therapeutics NK Cells Product Portfolios and Specifications &nbsp;13.6.3 Sorrento Therapeutics NK Cells Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Sorrento Therapeutics Main Business Overview &nbsp;13.6.5 Sorrento Therapeutics Latest Developments &nbsp;13.7 NantKwest &nbsp;13.7.1 NantKwest Company Information &nbsp;13.7.2 NantKwest NK Cells Product Portfolios and Specifications &nbsp;13.7.3 NantKwest NK Cells Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 NantKwest Main Business Overview &nbsp;13.7.5 NantKwest Latest Developments &nbsp;13.8 Bristol-Myers Squibb &nbsp;13.8.1 Bristol-Myers Squibb Company Information &nbsp;13.8.2 Bristol-Myers Squibb NK Cells Product Portfolios and Specifications &nbsp;13.8.3 Bristol-Myers Squibb NK Cells Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Bristol-Myers Squibb Main Business Overview &nbsp;13.8.5 Bristol-Myers Squibb Latest Developments &nbsp;13.9 NKT &nbsp;13.9.1 NKT Company Information &nbsp;13.9.2 NKT NK Cells Product Portfolios and Specifications &nbsp;13.9.3 NKT NK Cells Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 NKT Main Business Overview &nbsp;13.9.5 NKT Latest Developments &nbsp;13.10 Henry Ford Health Services &nbsp;13.10.1 Henry Ford Health Services Company Information &nbsp;13.10.2 Henry Ford Health Services NK Cells Product Portfolios and Specifications &nbsp;13.10.3 Henry Ford Health Services NK Cells Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Henry Ford Health Services Main Business Overview &nbsp;13.10.5 Henry Ford Health Services Latest Developments &nbsp;13.11 Fortress Biotech &nbsp;13.11.1 Fortress Biotech Company Information &nbsp;13.11.2 Fortress Biotech NK Cells Product Portfolios and Specifications &nbsp;13.11.3 Fortress Biotech NK Cells Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Fortress Biotech Main Business Overview &nbsp;13.11.5 Fortress Biotech Latest Developments 14 Research Findings and Conclusion

Report	Global NK Cells Market Growth 2025-2031
Selected License	Multi ID: LPI21317

Buyer Information

Order Summary